Nurix Therapeutics Inc. (NRIX)
NASDAQ · Healthcare
Nurix Therapeutics Inc. Shareholder Equity 2019–2025
Nurix Therapeutics Inc. annual shareholder equity history from 2019 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Nurix Therapeutics Inc. shareholder equity as of November 30, 2025: 538.7M, a 2.23% increase year-over-year.
- Nurix Therapeutics Inc. shareholder equity for 2025 were 538.7M, a 2.23% increase from 2024.
- Nurix Therapeutics Inc. shareholder equity for 2024 were 527.0M, a 162.85% increase from 2023.
- Nurix Therapeutics Inc. shareholder equity for 2023 were 200.5M, a 33.98% decrease from 2022.
- Nurix Therapeutics Inc. shareholder equity for 2022 were 303.7M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Nurix Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $539 |
| 2024 | $527 |
| 2023 | $200 |
| 2022 | $304 |
| 2021 | $342 |
| 2020 | $290 |
| 2019 | $-58 |
Nurix Therapeutics Inc. Shareholder Equity — FAQ
Nurix Therapeutics Inc. (NRIX) shareholder equity over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NRIX's shareholder equity history?
The chart and table above show Nurix Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.